05.13.25 -- Partners Prepared For Your Aseptic Fill/Finish Needs

Enhance your injectable projects with our expertise and expanded capacity to meet the demand for vials, pre-filled syringes, and cartridges from pre-clinical development to commercial launch.

Explore how our proven expertise and simplified execution with development, filling, and analytical under one roof ensure safe, efficacious products reach patients in need.

Our 87,000 sq. ft. cGMP-certified drug product manufacturing facility, located in Baltimore, Maryland, offers aseptic fill/finish manufacturing of biologics and sterile injectables.

Learn how delivering a comprehensive CMC package under a single manufacturer can minimize the logistical complexity of multiple vendors that leads to major risks for program success.

Argonaut features state-of-the-art automated equipment for high-yield filling of sterile injectable drugs, supported by a full analytical QC service offering, warehousing, and global shipping logistics.

Regulatory agencies prefer terminal sterilization over aseptic manufacturing, but is it suitable for your product? Industry manufacturing experts guide you in the selection and final delivery.

This presentation showcases our extensive range of offerings, including our advanced high-speed, multi-purpose fill/finish line designed for vials, syringes, and cartridges.

Equipped with advanced isolator and RABs technologies, our aseptic filling facilities feature multiple filling lines capable of producing liquid and lyophilized vials as well as prefilled syringes.